FIELD: medicine; experimental cardiology.
SUBSTANCE: for this purpose animal's arterial pressure is increased with multiple factors. Prescribed cardiovasonephropathogenic semisynthetic diet is cholesterol enriched, charged with twice-substituted aqueous sodium phosphate in combination with potassium and magnesium deficit. Besides, hydrocortisone acetate suspension is daily intramuscularly injected in dosage 1.5 mg per 100 g of animal body weight. Simultaneously drinking water is substituted with 1% sodium chloride solution followed by cold exposure in 2 weeks of rats keeping during 4 hours at 4°C.
EFFECT: enables to produce new experimental model of arterial hypertension; easy performed; notable for good reproducibility, absence of fatal outcome of experimental animals and complex exposure to circulatory homeostasis.
1 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATING RENOPARENCHYMATOUS ARTERIAL HYPERTENSION IN RATS | 2012 |
|
RU2507593C1 |
| INDOL DERIVATIVE DISPLAYING ANTIHYPERTENSIVE ACTION AND ITS PRODUCTION METHOD | 2010 |
|
RU2451670C2 |
| METHOD OF SIMULATING ATHEROSCLEROSIS | 2012 |
|
RU2500041C1 |
| METHOD OF MODELLING ENDOTHELIAL DYSFUNCTION BY REPRODUCTION OF METABOLIC DISORDERS | 2009 |
|
RU2412714C1 |
| NEUROPROTECTIVE AGENT | 2021 |
|
RU2765956C1 |
| METHOD FOR COMPLEX EVALUATION OF VASOMOTOR FUNCTION OF VASCULAR ENDOTHELIUM | 2001 |
|
RU2209587C2 |
| COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT | 2011 |
|
RU2464019C1 |
| METHOD OF SIMULATING MULTIPLE ORGAN PATHOLOGY IN RATS | 2011 |
|
RU2453002C1 |
| AGENT FOR TREATING PULMONARY HYPERTENSION | 2023 |
|
RU2813890C1 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY COMBINATION OF TRIMETAZIDINE AND L-ARGININE IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2421822C2 |
